Baxion
Screening
Tags
Alerts
Theme
Skye Bioscience, Inc.
SKYE
·
NASDAQ
·
$0.82
Share Price as of 11/2
·
$26M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/14/26
10-Q
Q1 ended 03/31/26
05/11/26
10-K
FY 2025
03/10/26
10-Q
Q3 ended 09/30/25
11/10/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
09/11/26
8-K
Current report
08/24/26
8-K/A
Current report (amended)
08/20/26
8-K
Current report
08/19/26
8-K
Current report
08/14/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
03/11/26
S-8
Registration of securities for employees
03/20/25
S-8
Registration of securities for employees
11/07/24
S-8
Registration of securities for employees
08/12/24
S-8
Registration of securities for employees
08/09/24
Proxies
Filter
PRER14A
Preliminary proxy (revised)
10/28/26
PREM14A
Preliminary proxy (merger)
10/26/26
DEFA14A
Additional proxy materials
09/11/26
DEFA14A
Additional proxy materials
08/24/26
DEFA14A
Additional proxy materials
08/20/26
Ownership
Filter
SC 13G
Beneficial ownership
10/14/26
Form 4
Insider transaction
09/24/26
Form 4
Insider transaction
09/24/26
SC 13D/A
Beneficial ownership (amended)
09/24/26
Form 4
Insider transaction
09/18/26
Other
Filter
ARS
Annual report to shareholders
04/16/26
ARS
Annual report to shareholders
04/25/25
UPLOAD
Letter from the SEC
02/05/25
CORRESP
Correspondence with the SEC
12/23/24
UPLOAD
Letter from the SEC
12/16/24
Latest Filings
Filter
PRER14A
Preliminary proxy (revised)
10/28/26
PREM14A
Preliminary proxy (merger)
10/26/26
8-K
Current report
09/11/26
DEFA14A
Additional proxy materials
09/11/26
8-K
Current report
08/24/26
Ownership
Filter
SC 13G
Beneficial ownership
10/14/26
Form 4
Insider transaction
09/24/26
Form 4
Insider transaction
09/24/26
SC 13D/A
Beneficial ownership (amended)
09/24/26
Form 4
Insider transaction
09/18/26